Skip to content

Clinical trials

Hepatitis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: Germany Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20064
20071
20093
20101
20112
20121
20141
20171
20202
20212
20223
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vir Biotechnology, Inc.6
Gilead Sciences3
Dynavax Technologies Corporation2
GlaxoSmithKline2
Human Genome Sciences Inc.2
AbbVie1
Alexion Pharmaceuticals, Inc.1
Bristol-Myers Squibb1
Conatus Pharmaceuticals Inc.1
Debiopharm International SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis26
Hepatitis C10
Hepatitis B7
Hepatitis B, Chronic6
Hepatitis C, Chronic5
Hepatitis D4
Hepatitis D, Chronic4
Liver Diseases4
Digestive System Diseases3
Hepatitis, Chronic3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.